NCT00961116View on ClinicalTrials.gov

Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

Fenofibric Acid (Fibricor™) 105 mg Tablet

1 x 105 mg fenofibric acid (Fibricor™) tablet administered after an overnight fast of at least 10 hours

DRUG

Fenofibrate (Tricor®) 145 mg Tablet

1 x 145 mg Fenofibrate (Tricor®) tablet administered after an overnight fast of at least 10 hours

Trial Locations (1)

58104

PRACS Institute, Ltd. - Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00961116 - Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate) | Biotech Hunter | Biotech Hunter